Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tessa Romero. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Taylor Hanley and Adhiraj Chauhan from the team.
Our next presenting company is Y-mAbs Therapeutics. And speaking on behalf of the company, we have Founder, Thomas Gad.
Before I turn it over to Thomas, I just wanted to highlight for that -- for the Q&A after this formal presentation, there is an ask-a-question button in the portal, and I'm happy to ask the question on your behalf. We will also be taking live questions here in the room.
So with that, Thomas, over to you.
Hello, everyone, and thank you for listening into today's presentation of Y-mAbs Therapeutics. Y-mAbs is a commercial-stage biopharmaceutical company founded on technology spun out of Memorial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |